Guanfacine HCl — Medicare Part D Spending

Generic: Guanfacine HCl | Manufacturer: Overall

2023 Spending

$4.7M

2023 Claims

111,820

2023 Beneficiaries

22,464

Cost/Unit (2023)

$0.6473

5-Year Spending Trend (2019-2023)

Year	Total Spending	Claims	Beneficiaries	Cost/Unit
2019	$2.9M	82,275	17,913	$0.5470
2020	$3.8M	89,987	17,673	$0.6248
2021	$4.0M	97,173	19,293	$0.6095
2022	$4.5M	102,390	20,116	$0.6614
2023	$4.7M	111,820	22,464	$0.6473

5Y CAGR (cost/unit): 4.3%YoY Change (2022-2023): -2.1%

📊

DrugPricePeek Editorial TeamData Specialists

The DrugPricePeek editorial team aggregates and verifies drugs data from CMS NADAC & Medicare Part D. Every statistic on this site is cross-referenced against the official source before publication, with quarterly re-verification cycles.

✓ Sourced from CMS NADAC & Medicare Part D✓ Quarterly review✓ No paid placements

Read our full methodology or contact us with corrections.

Frequently Asked Questions

How much does Medicare spend on Guanfacine HCl?

In 2023, Medicare Part D spent $4.7M on Guanfacine HCl (Guanfacine HCl), serving 22,464 beneficiaries across 111,820 claims.

What is the cost per unit of Guanfacine HCl under Medicare?

The weighted average cost per dosage unit of Guanfacine HCl was $0.6473 in 2023. The 5-year compound annual growth rate (2019-2023) was 4.3%.

Who manufactures Guanfacine HCl?

Guanfacine HCl (generic name: Guanfacine HCl) is manufactured by Overall. There are 7 manufacturer(s) listed in the CMS database for this drug.

Is Guanfacine HCl covered by Medicare Part D?

Yes, Guanfacine HCl is included in Medicare Part D spending data, indicating it is covered by Part D plans. However, specific coverage and tier placement vary by plan. Check with your specific Part D plan for formulary details.

Where does this Medicare spending data come from?

All Medicare Part D spending data comes from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Spending by Drug dataset, which is publicly available at data.cms.gov.

Explore More Data Tools

For adjacent public-data tools, methodology notes, and network updates, visit DataPeek Facts.

Year

Total Spending

Claims

Beneficiaries

Cost/Unit

2019

$2.9M

82,275

17,913

$0.5470

2020

$3.8M

89,987

17,673

$0.6248

2021

$4.0M

97,173

19,293

$0.6095

2022

$4.5M

102,390

20,116

$0.6614

2023